Advanced search
Publication Cover
International Journal of Chronic Obstructive Pulmonary Disease Volume 11, 2016 - Issue
Submit an article Journal homepage
72
Views
9
CrossRef citations to date
0
Altmetric
Original Research

Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study

Craig LaForce1 North Carolina Clinical Research, Raleigh, NC, USACorrespondence[email protected]
,
Gregory Feldman2 South Carolina Pharmaceutical Research, Spartanburg, SC, USA
,
Selwyn Spangenthal3 American Health Research, Charlotte, NC, USA
,
Joerg H Eckert4 Novartis Pharma AG, Basel, Switzerland
,
Michelle Henley5 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
,
Francesco Patalano4 Novartis Pharma AG, Basel, Switzerland
&
Peter D’Andrea5 Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
 show all
Pages 1233-1243 | Published online: 08 Jun 2016

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Edward Kerwin, Gregory Feldman, James Pearle, Luis De La Cruz, Melinda Edwards, Carolyn Beaudot & George Georges. (2021) Efficacy and Safety of Inhaled Glycopyrronium Bromide in COPD: A Randomized, Parallel Group, Dose-Ranging Study (GLIMMER). COPD: Journal of Chronic Obstructive Pulmonary Disease 18:2, pages 181-190.
Read now
Jill A Ohar, Alyssa Bowling, Thomas Goodin, Barry Price, Ayca Ozol-Godfrey, Sanjay Sharma & Shahin Sanjar. (2019) Efficacy and safety of glycopyrrolate in patients with COPD by reversibility: pooled analysis of GEM1 and GEM2 12-week studies. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 461-470.
Read now
Edward Kerwin & Gary T. Ferguson. (2018) An overview of glycopyrrolate/eFlow® CS in COPD. Expert Review of Respiratory Medicine 12:6, pages 447-459.
Read now
Donald P Tashkin & Nicholas J Gross. (2018) Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1873-1888.
Read now
Nicola A Hanania, Suzanne C. Lareau & Barbara P. Yawn. (2017) Safety of inhaled long-acting anti-muscarinic agents in COPD. Postgraduate Medicine 129:5, pages 500-512.
Read now

Articles from other publishers (4)

Wei-Chang Huang, Sheng-Hao Lin, Liang-Wen Hang, Ching-Hsiung Lin & Jeng-Yuan Hsu. (2022) The Effectiveness and Tolerability of Glycopyrronium for Patients with Chronic Obstructive Pulmonary Disease in a Clinical Setting: GLARE-Taiwan. Journal of Clinical Medicine 11:20, pages 6210.
Crossref
Chuchu Zhang, Meng Zhang, Yalei Wang, Huaiyu Xiong, Qiangru Huang, Tiankui Shuai & Jian Liu. (2023) Efficacy and Cardiovascular Safety of LAMA in Patients with COPD: A Systematic Review and Meta-Analysis. Journal of Investigative Medicine 69:8, pages 1391-1398.
Crossref
Ali Abdolahinia, Mohsen Naseri, Alireza Eslaminejad, Farzaneh Ghaffari & Aliakbar Velayati. (2018) Effect of Nepeta bracteata Benth. on Chronic Obstructive Pulmonary Disease: A Triple-Blinded, Randomized Clinical Trial. Iranian Red Crescent Medical Journal 20:12.
Crossref
Sharon R Rosenberg & Ravi Kalhan. (2017) Recent advances in the management of chronic obstructive pulmonary disease. F1000Research 6, pages 863.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.